Position in SGHT
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$908,196
+$569,224 QoQ
Shares Held
167,564
+86.4% QoQ
Ownership
0.304%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#25
of 111 holders
Holding Since
Jun 2022
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SGHT Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026GSA CAPITAL PARTNERS LLP holds $34,693,166 across 42 Medical Devices names. SGHT ranks #14 (2.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MDT |
Medtronic plc
|
68,541 | $5,361,962 | |
| 2 | NPCE |
NeuroPace Inc
|
115,535 | $1,835,851 | |
| 3 | QTRX |
Quanterix Corp
|
410,252 | $1,772,288 | |
| 4 | PODD |
Insulet Corp
|
11,310 | $1,721,947 | |
| 5 | INFU |
InfuSystem Holdings, Inc
|
160,439 | $1,548,236 | |
| 6 | VMD |
Viemed Healthcare, Inc.
|
127,591 | $1,454,537 | |
| 7 | BSX |
Boston Scientific Corp
|
32,095 | $1,369,814 | |
| 8 | DXCM |
Dexcom Inc
|
19,820 | $1,334,877 |
All Filings in SGHT
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $908,196 | 167,564 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $338,972 | 89,913 | Shares | Sole | 2026-05-08 | |
| 2025-03-31 | $126,350 | 52,646 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $170,959 | 46,967 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $135,538 | 21,514 | Shares | Sole | 2024-11-05 | |
| 2023-09-30 | $68,700 | 20,386 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $170,799 | 20,628 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $103,638 | 11,858 | Shares | Sole | 2023-05-12 | |
| 2022-09-30 | $290,271 | 45,712 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $213,979 | 23,802 | Shares | Sole | 2022-08-09 | |
| No filing history on record for this holder in this stock. | ||||||